Clinical Trial Update: Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating clofazimine for pulmonary Mycobacterium avium complex infection. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Mycobacterium Avium Complex Infection

Drugs mentioned

• Clofazimine (clofazimine)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Mycobacterium Avium Complex | Phase 2 | Status: ACTIVE_NOT_RECRUITING